BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹243 Cr | ₹210 Cr | ₹194 Cr | ₹141 Cr | ₹94 Cr |
What is the latest Total Current Assets ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹243 Cr |
| Mar2024 | ₹210 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹141 Cr |
| Mar2021 | ₹94 Cr |
How is Total Current Assets of BALAXI PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹243 Cr | 15.51 | |
| Mar2024 | ₹210 Cr | 8.61 | |
| Mar2023 | ₹194 Cr | 37.24 | |
| Mar2022 | ₹141 Cr | 50.37 | |
| Mar2021 | ₹94 Cr | - | |
Compare Total Current Assets of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹231.0 Cr | -2.6% | -4.1% | -53.6% | Stock Analytics | |
| ADANI ENTERPRISES | ₹273,552.0 Cr | -4.5% | -6.8% | -21.5% | Stock Analytics | |
| REDINGTON | ₹22,823.9 Cr | 15% | 6.1% | 49.6% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,127.2 Cr | -3.1% | -3.9% | 47.7% | Stock Analytics | |
| MMTC | ₹9,801.0 Cr | -4.9% | -4.4% | -17% | Stock Analytics | |
| HONASA CONSUMER | ₹8,900.5 Cr | -3.8% | -7.2% | -30% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.6% |
-4.1% |
-53.6% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses